Podcast series for professionals by Blood Cancer United

Treating Blood Cancers
Claim This Podcastby Blood Cancer United
Podcast Authority
Beta
Podcast Overview
Podcast series for professionals by Blood Cancer United
Language
🇺🇲
Publishing Since
1/2/2019
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
2 verified contact emails on file for Treating Blood Cancers
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

July 10, 2026
Waldenström macroglobulinemia: What to Know in Practice
<div class="wp-block-group is-layout-flow wp-block-group-is-layout-flow"> <p>Stephen Ansell, MD, PhD, Mayo Clinic, Rochester, MN</p> </div> <span id="more-35538"></span> <p></p> <p>Recorded on June 23, 2026</p><br> <div class="wp-block-group is-layout-flow wp-block-group-is-layout-flow"> <img style="float:left;padding-right:15px;padding-bottom:15px" alt="Stephen Ansell, MD, PhD "src="https://treatingbloodcancers.org/wp-content/uploads/2026/07/Dr.-Ansell-180x240-1.png" width="180" height="240"> <div style="line-height:1.2em"><strong>Stephen Ansell, MD, PhD </strong><br> Division Chair, Hematology <br> Mayo Clinic <br> Rochester, MN <br> <div style="clear:both;"></div></div> Join Dr. Stephen Ansell from Mayo Clinic for an in-depth discussion on Waldenström macroglobulinemia, focusing on the latest advances in diagnosis, treatment, and management. This episode explores clinical features, the importance of molecular markers in guiding diagnosis and treatment decisions, and current indications for initiating therapy. The discussion also addresses the management of IgM-related complications, emerging therapeutic approaches, and future directions in care. Listen to this exciting and informative episode today! </div> <p><strong>Blood Cancer United Resources:</strong></p> <ul class="wp-block-list"> <li><a href="http://www.bloodcancerunited.org/CE" target="_blank" rel="noreferrer noopener">Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education</a></li> <li><a href="https://bloodcancerunited.org/resources/patients" target="_blank" rel="noreferrer noopener">Blood Cancer United Resources for Patients</a></li> </ul> <div class="wp-block-buttons is-horizontal is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-03627597 wp-block-buttons-is-layout-flex"></div> <p></p>

June 25, 2026
Mastocytosis: What Clinicians Need to Know
<div class="wp-block-group is-layout-flow wp-block-group-is-layout-flow"> <p>Marina Kremyanskaya, MD, PhD, Icahn School of Medicine at Mount Sinai, New York, NY</p> </div> <span id="more-26022"></span> <p></p> <p>Recorded on June 2, 2026</p><br> <div class="wp-block-group is-layout-flow wp-block-group-is-layout-flow"> <img style="float:left;padding-right:15px;padding-bottom:15px" alt="Marina Kremyanskaya, MD, PhD "src="https://treatingbloodcancers.org/wp-content/uploads/2026/06/Dr.-K-180x240-1.png" width="180" height="240"> <div style="line-height:1.2em"><strong>Marina Kremyanskaya, MD, PhD </strong><br> Associate Professor <br> Tisch Cancer Institute <br> Icahn School of Medicine at Mount Sinai <br> New York, NY <br> <div style="clear:both;"></div></div> Join Dr. Marina Kremyanskaya from the Icahn School of Medicine at Mount Sinai in this expert discussion on mastocytosis, including an overview of the disease, key signs and symptoms, and current diagnostic criteria with a focus on relevant genetic mutations. She discusses recently approved therapies, emerging treatment approaches, and ongoing clinical trials that are shaping future treatment. The episode also covers approaches to managing complications, addressing treatment-related side effects, and delivering patient-centered care. Don’t miss this informative episode! </div> <p><strong>Blood Cancer United Resources:</strong></p> <ul class="wp-block-list"> <li><a href="http://www.bloodcancerunited.org/CE" target="_blank" rel="noreferrer noopener">Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education</a></li> <li><a href="https://bloodcancerunited.org/resources/patients" target="_blank" rel="noreferrer noopener">Blood Cancer United Resources for Patients</a></li> </ul> <div class="wp-block-buttons is-horizontal is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-03627597 wp-block-buttons-is-layout-flex"></div> <p></p>

June 15, 2026
CAR-T Today and Tomorrow: Clinical Decision-Making and Patient Support
<div class="wp-block-group is-layout-flow wp-block-group-is-layout-flow"> <p>Tara Gregory, MD, Colorado Blood Cancer Institute, Denver, CO and Jay Spiegel, MD, Sylvester Comprehensive Cancer Center, Miami, FL</p> </div> <span id="more-25320"></span> <p></p> <p>Recorded on May 28, 2026</p><br> <img style="float:left;padding-right:15px;padding-bottom:15px" alt="Tara Gregory, MD "src="https://treatingbloodcancers.org/wp-content/uploads/2026/06/180x240_Dr.-Gregory.png" width="180" height="240"> <div style="line-height:1.2em"><strong>Tara Gregory, MD </strong><br> President <br> Colorado Blood Cancer Institute <br> Denver, CO <br> <div style="clear:both;"></div></div> <div class="wp-block-group is-layout-flow wp-block-group-is-layout-flow"> <img style="float:left;padding-right:15px;padding-bottom:15px" alt="Jay Spiegel, MD "src="https://treatingbloodcancers.org/wp-content/uploads/2026/06/180x240_Dr.-Spiegel.png" width="180" height="240"> <div style="line-height:1.2em"><strong>Jay Spiegel, MD </strong><br> Assistant Professor <br> Division of Transplant and Cellular Therapy <br> University of Miami Sylvester Comprehensive Cancer Center <br> Miami, FL <br> <div style="clear:both;"></div></div> In this episode, Dr. Tara Gregory from the Colorado Blood Cancer Institute, and Dr. Jay Spiegel from the Sylvester Comprehensive Cancer Center discuss the evolving role of CAR T-cell therapy in lymphoma and myeloma. They provide a practical overview of CAR-T, including currently approved indications, importance of early referral, patient selection considerations, and strategies for engaging patients in treatment discussions. The conversation also covers key aspects of toxicity management and post-treatment monitoring, while addressing current limitations of CAR-T therapy and future directions that may further expand its role in patient care. Tune in today for this exciting episode! </div> <p><strong>Blood Cancer United Resources:</strong></p> <ul class="wp-block-list"> <li><a href="http://www.bloodcancerunited.org/CE" target="_blank" rel="noreferrer noopener">Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education</a></li> <li><a href="https://bloodcancerunited.org/resources/patients" target="_blank" rel="noreferrer noopener">Blood Cancer United Resources for Patients</a></li> </ul> <div class="wp-block-buttons is-horizontal is-content-justification-center is-layout-flex wp-container-core-buttons-is-layout-03627597 wp-block-buttons-is-layout-flex"></div> <p>This episode is supported by Bristol Myers Squibb, Johnson & Johnson & Legend Biotech, and Kite, a Gilead Company.</p> <p></p>
121 total episodes available
Recent guests on Treating Blood Cancers
Guests from recent episodes — sign up to see every guest that has ever appeared on this show.
Uma Borate
Guest
Dr Aaron Gerds
Guest
Celeste Bello
Guest
Similar Podcasts
Discover related shows you might enjoy

Two Onc Docs
Sam and Karine

Blood Cancer Talks
Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff

The Bloodline with LLS
Blood Cancer United

Blood Podcast
American Society of Hematology

Hematologic Oncology Update
Dr. Neil Love

Stuff You Should Know
iHeartPodcasts

VJHemOnc Podcast
VJHemOnc

JAMA Clinical Reviews
JAMA Network

Cautionary Tales with Tim Harford
Pushkin Industries

The HemOnc Pulse
Rahul Banerjee, MD

Science Vs
Spotify Studios

WolverHeme Happy Hour
Bernard Marini, Anthony Perissinotti, et al.

The Genius Life
Max Lugavere

The Ezra Klein Show
New York Times Opinion

All There Is with Anderson Cooper
CNN Podcasts
Deep-dive analytics for Treating Blood Cancers
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Treating Blood Cancers?
- How often does this podcast release new episodes?
This podcast updates weekly.
- Where can I listen to this podcast?
This podcast is available on 9 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.